271 related articles for article (PubMed ID: 19151111)
21. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
Yamaji K; Kim YJ; Tsuda H; Takasaki Y
Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
[TBL] [Abstract][Full Text] [Related]
22. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
[TBL] [Abstract][Full Text] [Related]
23. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F
Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
[TBL] [Abstract][Full Text] [Related]
25. Update on the treatment of lupus nephritis.
Hogan J; Appel GB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):224-30. PubMed ID: 23328501
[TBL] [Abstract][Full Text] [Related]
26. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC
Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041
[TBL] [Abstract][Full Text] [Related]
27. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
[TBL] [Abstract][Full Text] [Related]
28. The long-term outcome of 93 patients with proliferative lupus nephritis.
Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
[TBL] [Abstract][Full Text] [Related]
29. Major lupus organ involvement: severe lupus nephritis.
Avihingsanon Y; Hirankarn N
Lupus; 2010 Oct; 19(12):1391-8. PubMed ID: 20947547
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?
Wetzels JF
Neth J Med; 2004 Nov; 62(10):347-52. PubMed ID: 15683089
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of kidney disease.
Cross J; Jayne D
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):785-98. PubMed ID: 16150403
[TBL] [Abstract][Full Text] [Related]
32. Lupus nephritis: pathophysiology, diagnosis, and collaborative management.
Smith DM; Fortune-Faulkner EM; Spurbeck BL
Nephrol Nurs J; 2000 Apr; 27(2):199-204, 209-11. PubMed ID: 11111547
[TBL] [Abstract][Full Text] [Related]
33. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
[TBL] [Abstract][Full Text] [Related]
34. Membranous Lupus Nephritis: The Same, But Different.
Ward F; Bargman JM
Am J Kidney Dis; 2016 Dec; 68(6):954-966. PubMed ID: 27663040
[TBL] [Abstract][Full Text] [Related]
35. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
36. Thirty years of cyclophosphamide: assessing the evidence.
Houssiau F
Lupus; 2007; 16(3):212-6. PubMed ID: 17432109
[TBL] [Abstract][Full Text] [Related]
37. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
[TBL] [Abstract][Full Text] [Related]
38. [Treatments of lupus nephropathies].
Delahousse M
Ann Med Interne (Paris); 1996; 147(7):507-12. PubMed ID: 9092362
[TBL] [Abstract][Full Text] [Related]
39. Moderator's view: Cyclophosphamide in lupus nephritis.
Tesar V
Nephrol Dial Transplant; 2016 Jul; 31(7):1058-61. PubMed ID: 27190357
[TBL] [Abstract][Full Text] [Related]
40. Lupus nephritis: an update.
Imran TF; Yick F; Verma S; Estiverne C; Ogbonnaya-Odor C; Thiruvarudsothy S; Reddi AS; Kothari N
Clin Exp Nephrol; 2016 Feb; 20(1):1-13. PubMed ID: 26471017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
